Vijaya Raj Bhatt

7.9k total citations · 1 hit paper
245 papers, 3.2k citations indexed

About

Vijaya Raj Bhatt is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Vijaya Raj Bhatt has authored 245 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Hematology, 75 papers in Oncology and 54 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Vijaya Raj Bhatt's work include Acute Myeloid Leukemia Research (74 papers), Acute Lymphoblastic Leukemia research (47 papers) and Lymphoma Diagnosis and Treatment (34 papers). Vijaya Raj Bhatt is often cited by papers focused on Acute Myeloid Leukemia Research (74 papers), Acute Lymphoblastic Leukemia research (47 papers) and Lymphoma Diagnosis and Treatment (34 papers). Vijaya Raj Bhatt collaborates with scholars based in United States, Nepal and India. Vijaya Raj Bhatt's co-authors include Smith Giri, Basem Azab, Prajwal Dhakal, Ranjan Pathak, Srujitha Murukutla, Warren D. Widmann, Terenig Terjanian, Jamés O. Armitage, Nina Kohn and Krishna Gundabolu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Vijaya Raj Bhatt

232 papers receiving 3.2k citations

Hit Papers

Usefulness of the Neutrophil-to-Lymphocyte Ratio in Predi... 2011 2026 2016 2021 2011 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vijaya Raj Bhatt United States 26 1.4k 941 434 415 384 245 3.2k
Dianne Pulte United States 31 1.4k 1.0× 1.4k 1.5× 690 1.6× 308 0.7× 255 0.7× 87 3.5k
Ralph M. Meyer Canada 36 1.7k 1.2× 1.5k 1.5× 431 1.0× 606 1.5× 335 0.9× 139 4.7k
Smith Giri United States 29 991 0.7× 1.2k 1.3× 400 0.9× 400 1.0× 188 0.5× 262 3.2k
Gerardo Colón‐Otero United States 30 2.0k 1.4× 407 0.4× 199 0.5× 618 1.5× 331 0.9× 99 3.5k
Ulrich Mey Germany 25 1.5k 1.1× 854 0.9× 127 0.3× 222 0.5× 387 1.0× 68 2.9k
Stephen Couban Canada 29 765 0.5× 1.4k 1.5× 463 1.1× 191 0.5× 377 1.0× 98 3.0k
Jan‐Stephan Sanders Netherlands 34 848 0.6× 1.8k 1.9× 528 1.2× 508 1.2× 875 2.3× 168 4.2k
Glenn Mills United States 26 1.9k 1.3× 428 0.5× 185 0.4× 340 0.8× 172 0.4× 119 3.4k
Wael Saber United States 31 869 0.6× 2.7k 2.8× 822 1.9× 177 0.4× 667 1.7× 173 3.7k
Dirk Schrijvers Belgium 21 800 0.6× 771 0.8× 135 0.3× 223 0.5× 373 1.0× 62 2.3k

Countries citing papers authored by Vijaya Raj Bhatt

Since Specialization
Citations

This map shows the geographic impact of Vijaya Raj Bhatt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vijaya Raj Bhatt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vijaya Raj Bhatt more than expected).

Fields of papers citing papers by Vijaya Raj Bhatt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vijaya Raj Bhatt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vijaya Raj Bhatt. The network helps show where Vijaya Raj Bhatt may publish in the future.

Co-authorship network of co-authors of Vijaya Raj Bhatt

This figure shows the co-authorship network connecting the top 25 collaborators of Vijaya Raj Bhatt. A scholar is included among the top collaborators of Vijaya Raj Bhatt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vijaya Raj Bhatt. Vijaya Raj Bhatt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alvarado, Yesid, Rachel J. Cook, Shira Dinner, et al.. (2025). The oral CDK9 inhibitor voruciclib combined with venetoclax for patients with relapsed/refractory acute myeloid leukemia. PubMed. 2(3). 100108–100108. 1 indexed citations
2.
Dhakal, Prajwal, J. O. Armitage, & Vijaya Raj Bhatt. (2025). Academic and community cancer center collaboration in acute myeloid leukemia: a road map to optimize care delivery. Leukemia & lymphoma. 66(8). 1389–1399.
3.
Bhatt, Vijaya Raj, et al.. (2025). Chemotherapy Trends in Acute Myeloid Leukemia: 2004 to 2020. Clinical Lymphoma Myeloma & Leukemia. 25(8). e541–e552.
4.
Davids, Matthew S., Danielle M. Brander, Yesid Alvarado, et al.. (2024). A phase 1 study of the CDK9 inhibitor voruciclib in relapsed/refractory acute myeloid leukemia and B-cell malignancies. Blood Advances. 9(4). 820–832. 3 indexed citations
5.
Ellithi, Moataz, et al.. (2024). Metabolic syndrome and symptom burden in allogeneic hematopoietic stem cell transplantation survivors. Future Oncology. 20(40). 3403–3408. 1 indexed citations
6.
Bhatt, Vijaya Raj, Geoffrey L. Uy, & Heidi D. Klepin. (2023). Determining treatment tolerance and fitness for intensive chemotherapy in older adults with AML: a call to action. Blood. 143(6). 483–487. 18 indexed citations
8.
Chaaban, Said, Andrea Zimmer, Vijaya Raj Bhatt, Cynthia Schmidt, & Ruxana T. Sadikot. (2023). Bacterial Pathogens Causing Pneumonia Post Hematopoietic Stem Cell Transplant: The Chronic GVHD Population. Pathogens. 12(5). 726–726. 1 indexed citations
9.
Wall, Sarah, Rebecca L. Olin, Vijaya Raj Bhatt, et al.. (2023). The Transplantation Ecosystem: A New Concept to Improve Access and Outcomes for Older Allogeneic Hematopoietic Cell Transplantation Patients. Transplantation and Cellular Therapy. 29(10). 632.e1–632.e10. 8 indexed citations
10.
Abbasi, Muhannad, et al.. (2023). Cardiotoxicities of Novel Therapies in Hematologic Malignancies: Chimeric Antigen Receptor T-Cell Therapy and Bispecific T-Cell Engager Therapy. JCO Oncology Practice. 19(6). 331–342. 9 indexed citations
11.
Nepal, Gaurav, et al.. (2023). EFFICACY OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN ADULT BURKITT/BURKITT-LIKE LYMPHOMA: A SYSTEMATIC REVIEW. Experimental Oncology. 44(3). 190–197. 1 indexed citations
13.
Mayor, Neema P., Tao Wang, Stephanie J. Lee, et al.. (2021). Impact of Previously Unrecognized HLA Mismatches Using Ultrahigh Resolution Typing in Unrelated Donor Hematopoietic Cell Transplantation. Journal of Clinical Oncology. 39(21). 2397–2409. 27 indexed citations
15.
Gundabolu, Krishna, Vijaya Raj Bhatt, Matthew A. Lunning, & Muhamed Baljević. (2017). Efficacy of Direct Oral Anticoagulants (DOAC) in Patients with Antiphospholipid Antibody Syndrome (APS). Blood. 130. 4917–4917. 3 indexed citations
16.
Aryal, Madan Raj, Ranjan Pathak, Smith Giri, & Vijaya Raj Bhatt. (2017). Recent Trends in the Incidence and Outcomes of Thrombotic Thrombocytopenic Purpura in the United States: Data from the 2009-2014 National Inpatient Sample. Blood. 130. 2086–2086. 2 indexed citations
17.
Chen, Baojiang, et al.. (2017). Socioeconomic Factors Associated with Overall Survival (OS) in Adults with Acute Lymphoblastic Leukemia (ALL). Blood. 130. 3431–3431. 2 indexed citations
18.
Murukutla, Srujitha, et al.. (2012). Recurrent Primary Laryngeal Amyloidosis in a 36 Year-Old-Woman. Journal of Medical Cases. 4(1). 46–48. 2 indexed citations
19.
Gupta, Shilpi, et al.. (2011). Recurrent imatinib-induced hepatotoxicity in a chronic myeloid leukaemia patient successfully managed with prednisone: Table 1. BMJ Case Reports. 2011. bcr1120103516–bcr1120103516. 5 indexed citations
20.
Bhatt, Vijaya Raj, et al.. (2007). Relative efficacy of soil test methods to measure changes in K status due to uptake, addition and release of potassium in calcareous soil under continuous cropping.. AN ASIAN JOURNAL OF SOIL SCIENCE. 2(1). 28–32. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026